DUBLIN--(BUSINESS WIRE)--The "Hemoglobin A1c Monitoring - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ by the following Test Types:
- HbA1c Laboratory Testing
- HbA1c Point of Care Testing
The report profiles 27 companies including many key and niche players such as:
- A. Menarini Diagnostics Ltd. (UK)
- Abbott Laboratories (USA)
- Alere, Inc. (USA)
- ARKRAY, Inc. (Japan)
- Beckman Coulter, Inc. (USA)
- Bio-Rad Laboratories, Inc. (USA)
- Diazyme Laboratories, Inc. (USA)
- EKF Diagnostics Holdings Plc (UK)
- HemoCue AB (Sweden)
- OSANG Healthcare Co., Ltd (South Korea)
- PTS Diagnostics (USA)
- Roche Diagnostics (Switzerland)
- Siemens Healthineers (Germany)
- Tosoh Bioscience, Inc. (USA)
- Trinity Biotech plc (Ireland)
Key Topics Covered:
1. Industry Overview
2. Growth Drivers, Trends And Issues
3. Diabetes - A Brief Profile Of The Disease
4. Product Overview
5. Product Innovations
Introductions
6. Recent Industry Activity
7. Focus On Select Players
8. Global Market Perspective
Total Companies Profiled: 28 (including Divisions
